XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. is a biopharmaceutical company that reached public markets through a SPAC transaction, filing an 8-K with the Securities and Exchange Commission on May 2, 2019, under accession number 0001213900-19-007632. The company, identified in SEC records under CIK 0001697805, operates in the healthcare and pharmaceutical sector with a focus on oncology therapeutics. The 8-K filing represents a current report disclosure consistent with a post-combination reporting period, reflecting an active regulatory filing status as of that date. For complete filing history, sponsor details, and deal timeline data on Xynomic Pharmaceuticals Holdings and thousands of other SPAC transactions, sign up for full access at SpacDesk.